Now online in Cancer Discovery @aacrjournals.bsky.social: Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers - by Giulia Montuori, Fengyu Tu, anton-henssen.bsky.social, Jan DΓΆrr, and colleagues doi.org/10.1158/2159...
13.08.2025 11:30 β π 17 π 4 π¬ 1 π 0
Very excited to see our new study out today - just in time for my talk annual EACR conference @helloeacr.bsky.social
18.06.2025 11:12 β π 16 π 2 π¬ 0 π 0
π¨We want your abstract! Submit your Late Breaking Abstract to #EANO2025 by June 25, 2025 to become an essential part of the state-of-the art scientific programme. π Learn more: eano.eu/eano2025/abs... #NeuroOncology #NeuroSurgery #cancernurse #braintumor #btsm
17.06.2025 19:19 β π 3 π 1 π¬ 0 π 0
Glad to see this out, very helpful resource for the community!
06.05.2025 23:44 β π 1 π 0 π¬ 0 π 0
Thanks for the invite, Alex! I really enjoyed both the chance to give a talk and the uniquely Swedish welcome, w/two MalmΓΆ goals included. Big relief I didnβt jinx it! π
08.04.2025 17:00 β π 5 π 0 π¬ 1 π 0
Evolutionary fingerprints of epithelial-to-mesenchymal transition - Nature
Malignant cells with mesenchymal features display increased chromatin accessibility, particularly in the pericentromeric and centromeric regions, in turn resulting in delayed mitosis and catastrophic ...
"EMT favours the emergence of genomic-unstable, highly fit tumour cells, which strongly supports the concept of cell-state-restricted patterns of evolution" Exceptional work addressing a classic chicken & egg paradigm in cell-state-driven tumor evolution. Congrats Gianni, Luigi & teams!
06.03.2025 07:49 β π 7 π 1 π¬ 1 π 0
βWe are almost ready for the test flight. All we need is the license." ...in Germany that may take much longer than developing and building the rocket π
22.02.2025 08:28 β π 2 π 1 π¬ 1 π 0
π€£π€£π€£
22.02.2025 09:30 β π 0 π 0 π¬ 0 π 0
Above all, I find it incredibly inspiring that a scientist with four decades of groundbreaking work is still leading discoveries, firsthand, literally. For some, curiosity and rigor never age. This one is special π
22.02.2025 08:50 β π 1 π 0 π¬ 0 π 0
RNA polymerase II at histone genes predicts outcome in human cancer
Genome-wide hypertranscription is common in human cancer and predicts poor prognosis. To understand how hypertranscription might drive cancer, we applied our formalin-fixed paraffin-embedded (FFPE)βcl...
Exciting tech advance 4 cancer research: FFPE-CUTAC enables phenotype queries from archived FFPE tissues. This finds a striking correlation between hypertranscription of histones (but not ribosomal genes) & chromosome arm losses, hence, cancer evolution.
22.02.2025 08:50 β π 6 π 1 π¬ 1 π 0
@science.org RNA polymerase II at histone genes predicts outcome in human cancer π§¬π @fredhutch.bsky.social @hhmi.bsky.social www.science.org/doi/10.1126/...
16.02.2025 23:25 β π 48 π 25 π¬ 4 π 1
π¬ #FundamentalResearch is key for #EUcompetitiveness
20.02.2025 10:58 β π 3 π 3 π¬ 0 π 0
Someone finally said it out loud.
20.02.2025 12:29 β π 2 π 1 π¬ 0 π 0
Amazing
20.02.2025 12:12 β π 78 π 9 π¬ 0 π 2
Normalize calling Republicans Nazis.
20.02.2025 11:51 β π 1232 π 264 π¬ 15 π 6
Delighted to share the published version of this work from brilliant #CancerNeuroscience post-doc Tara Barron detailing GABAergic neuron-to-glioma synapses in #DIPG/#DMG. π§΅
Open access link:
www.nature.com/articles/s41...
19.02.2025 21:41 β π 74 π 23 π¬ 2 π 0
1/I am delighted to share a new Cancer Discovery paper about metabolism and clinical outcomes in patients with non-small cell lung cancer (NSCLC). From Ling Cai and Brandon
@faubert.bsky.social, @cri-utsw.bsky.social and UT Southwestern McDermott Center.
17.02.2025 19:23 β π 37 π 10 π¬ 3 π 1
Injectable fluorescent retro-tracing of pancreatic cancer innervation. Denervation sensitizes PDAC to immunotherapy by counteracting neuronal suppression of acute inflammation in CAFs. Plus, tumor denervation as a novel mechanism behind the old nab-paclitaxel combo. Quite a characterization indeed!
18.02.2025 14:49 β π 1 π 0 π¬ 0 π 0
congrats Victor! Looking forward to reading it!
18.02.2025 13:23 β π 1 π 0 π¬ 1 π 0
Cell identity lives from constraints and dies from freedom
14.02.2025 22:18 β π 1 π 0 π¬ 0 π 0
Who knew theyβd give you more than cavities? π
- great to see this on the cover @GuccioneLab!
12.02.2025 21:31 β π 1 π 0 π¬ 0 π 0
Proud to see our labβs work contribute to this fantastic study, and specifically: "[...]We have recently developed a new strategy to genetically trace cell fate transitions within a heterogeneous tissue37,38 [...]" Check it out! π
10.02.2025 18:58 β π 3 π 1 π¬ 1 π 0
1) Huge thanks to @guccionelab.bsky.social @nickbarker @marinelab.bsky.social @ggargiul.bsky.social
@owensansom 4 the fantastic collaboration. NIH funding #EarlyStageInvestigator. Towards #BetterTherapeuticStrategies 4 #CRC patients #Oncofetal #CRC #IntratumoralHeterogeneity #PhenotypicPlasticity
10.02.2025 15:18 β π 4 π 3 π¬ 0 π 0
Now online in Cancer Discovery: PKN2 Is a Dependency of the Mesenchymal-like Cancer Cell State - by Shane Killarney, Kris Wood and colleagues doi.org/10.1158/2159...
20.11.2024 14:59 β π 24 π 3 π¬ 2 π 0
Associate Prof at Baylor College of Medicine. Brain tumor research at Texas Children's Hospital. Houston, TX. π¨π¦ in πΊπΈ
https://www.bcm.edu/research/faculty-labs/marco-gallo-lab
Soft spot for CRISPR and chaos. If it glows under the scope, I probably love it.
official account of the hovestadt lab @danafarber.bsky.social @bostonchildrens.bsky.social @broadinstitute.org. we study childhood brain tumors and leukemia using genomics and computational biology. learn more at https://hovestadtlab.github.io.
PhD candidate | Mathematical Modelling
Professor | Molecular Medicine | Halle University
We are using mass spectrometry to study the dynamic proteome in health and disease
dynamics of cancer by means of ecology & evolution, and modeling & simulation. views my own. https://paltrock.github.io/
Studying breast and ovarian cancer evolution and ecology using spatial metabolomics, lipidomics, proteomics, and transcriptomics at single cell resolution. Funded by NCI and NIH
We are studying tumor architecture to detail the constituent cell types controlling cancer initiation, spread and treatment response. Located @lund-university.bsky.social
We are studying childhood cancer neuroblastoma. Research about neuroblastoma metastasis, therapy escape and search for better treatment. Located at Lund University.
lab: https://www.tcr.lu.se/research-groups/molecular-pediatric-oncology
American/Swedish Biomedical Scientist studying immunology and cancer. My favorite cell atlases say βhere be dragonsβ on the UMAPs. @karolinska institute
https://scholar.google.com/citations?hl=en&user=_owb98cAAAAJ&view_op=list_works&sortby=pubdate
Cancer and molecular biology PhD candidate | Stunnenberg Lab | Prinses Maxima Centrum & Radboud University Nijmegen
Scientist with a passion for genomic integrity and a passion to optimally connect research and care in oncology.
@sinaibrain. Via @ColumbiaMed @Wakeforestmed. Studying glioblastoma and its immune microenvironment.
MD student in the Winkler Lab at the German Cancer Research Center, Heidelberg; interested in (brain) metastases and the tumor microenvironment
Emmy Noether Research Group Leader,
Professor for Molecular Pathology in Neuro-Oncology, Neuropathologist at University Hospital Hamburg-Eppendorf
Research Interests: Proteomics, DNA-methylomics, Bioinformatics, Preclinical Models,
Digital Pathology
*The necessity and power of random, under-sampled experiments in biology...
*π«-π, PERTURB-CAST, RUBIX...
Group leader at @CRGenomica and @icreacommunity, interested in understanding the role of chromatin organization/function in stem cell biology and in disease.
Group Leader-Cancer RNAs and Epigenetic group @Luxembourg Institute of Health. We study LncRNAs and RNA modifications in brain tumors
Professor at BIH@CharitΓ©, MDC and PHURI@QMUL